<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>da Silva RAG</submitter><funding>Wellcome Trust</funding><funding>University of Nottingham</funding><pubmed_abstract>Meningococcal lipoprotein, Factor H binding protein (FHbp), is the sole antigen of the Trumenba vaccine (Pfizer) and one of four antigens of the Bexsero vaccine (GSK) targeting &lt;i>Neisseria meningitidis&lt;/i> serogroup B isolates. Lipidation of FHbp is assumed to occur for all isolates. We show in the majority of a collection of United Kingdom isolates (1742/1895) non-synonymous single nucleotide polymorphisms (SNPs) in the signal peptide (SP) of FHbp. A single SNP, common to all, alters a polar amino acid that abolishes processing: lipidation and SP cleavage. Whilst some of the FHbp precursor is retained in the cytoplasm due to reduced binding to SecA, remarkably some is translocated and further surface-localized by Slam. Thus we show Slam is not lipoprotein-specific. In a panel of isolates</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>2847</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6930937</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates.</pubmed_title><pmcid>PMC6930937</pmcid><pubmed_authors>Oldfield NJ</pubmed_authors><pubmed_authors>Wooldridge KG</pubmed_authors><pubmed_authors>Ryan A</pubmed_authors><pubmed_authors>Karlyshev AV</pubmed_authors><pubmed_authors>Bayliss CD</pubmed_authors><pubmed_authors>Griffin R</pubmed_authors><pubmed_authors>da Silva RAG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates.</name><description>Meningococcal lipoprotein, Factor H binding protein (FHbp), is the sole antigen of the Trumenba vaccine (Pfizer) and one of four antigens of the Bexsero vaccine (GSK) targeting &lt;i>Neisseria meningitidis&lt;/i> serogroup B isolates. Lipidation of FHbp is assumed to occur for all isolates. We show in the majority of a collection of United Kingdom isolates (1742/1895) non-synonymous single nucleotide polymorphisms (SNPs) in the signal peptide (SP) of FHbp. A single SNP, common to all, alters a polar amino acid that abolishes processing: lipidation and SP cleavage. Whilst some of the FHbp precursor is retained in the cytoplasm due to reduced binding to SecA, remarkably some is translocated and further surface-localized by Slam. Thus we show Slam is not lipoprotein-specific. In a panel of isolates</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2026-05-04T09:04:52.714Z</modification><creation>2020-05-22T10:17:26Z</creation></dates><accession>S-EPMC6930937</accession><cross_references><pubmed>31921030</pubmed><doi>10.3389/fmicb.2019.02847</doi></cross_references></HashMap>